These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 36639250)

  • 1. Non-invasive prenatal testing for the detection of trisomies 21, 18, and 13 in pregnant women with various clinical indications: A multicenter observational study of 1,854,148 women in China.
    Xiang L; Zhu J; Deng K; Li Q; Tao J; Li M; Wang Y; Yuan X; Yao Y; Li X
    Prenat Diagn; 2023 Jul; 43(8):1036-1043. PubMed ID: 36639250
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genomics-based non-invasive prenatal testing for detection of fetal chromosomal aneuploidy in pregnant women.
    Badeau M; Lindsay C; Blais J; Nshimyumukiza L; Takwoingi Y; Langlois S; Légaré F; Giguère Y; Turgeon AF; Witteman W; Rousseau F
    Cochrane Database Syst Rev; 2017 Nov; 11(11):CD011767. PubMed ID: 29125628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Non-invasive prenatal test findings in 41,819 pregnant women: results from a clinical laboratory in southern China.
    Liu S; Chang Q; Yang F; Xu Y; Jia B; Wu R; Li L; Yin A; Chen W; Huang F; Yang X; Li F
    Arch Gynecol Obstet; 2023 Sep; 308(3):787-795. PubMed ID: 36602559
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-invasive prenatal testing for the detection of trisomy 13, 18, and 21 and sex chromosome aneuploidies in 68,763 cases.
    Zhang Y; Xu H; Zhang W; Liu K
    Front Genet; 2022; 13():864076. PubMed ID: 36186462
    [No Abstract]   [Full Text] [Related]  

  • 5. Performance of cell-free DNA sequencing-based non-invasive prenatal testing: experience on 36,456 singleton and multiple pregnancies.
    La Verde M; De Falco L; Torella A; Savarese G; Savarese P; Ruggiero R; Conte A; Fico V; Torella M; Fico A
    BMC Med Genomics; 2021 Mar; 14(1):93. PubMed ID: 33785045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the Z-score accuracy of noninvasive prenatal testing for fetal trisomies 13, 18 and 21 at a single center.
    Junhui W; Ru L; Qiuxia Y; Dan W; Xiuhong S; Yongling Z; Xiangyi J; Fatao L; Xuewei T; Guilan C; Fan J; Fucheng L; Fang F; Yan L; Lina Z; Cuixing Y; Jian L; Dongzhi L; Can L
    Prenat Diagn; 2021 May; 41(6):690-696. PubMed ID: 33480032
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience from Thailand: noninvasive prenatal testing as screening tests for trisomies 21, 18 and 13 in 4736 pregnancies.
    Manotaya S; Xu H; Uerpairojkit B; Chen F; Charoenvidhya D; Liu H; Petcharaburanin N; Liu Y; Tang S; Wang X; Dansakul S; Thomsopa T; Gao Y; Zhang H; Xu H; Jiang H
    Prenat Diagn; 2016 Mar; 36(3):224-31. PubMed ID: 26748603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical performance of non-invasive prenatal served as a first-tier screening test for trisomy 21, 18, 13 and sex chromosome aneuploidy in a pilot city in China.
    Liu Y; Liu H; He Y; Xu W; Ma Q; He Y; Lei W; Chen G; He Z; Huang J; Liu J; Liu Y; Huang Q; Yu F
    Hum Genomics; 2020 Jun; 14(1):21. PubMed ID: 32503639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Late first-trimester ultrasound findings can alter management after high-risk NIPT result.
    Scott F; Smet ME; Elhindi J; Mogra R; Sunderland L; Ferreira A; Menezes M; Meagher S; McLennan A
    Ultrasound Obstet Gynecol; 2023 Oct; 62(4):497-503. PubMed ID: 37247395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Next-generation sequencing: a follow-up of 36,913 singleton pregnancies with noninvasive prenatal testing in central China.
    Lu W; Huang T; Wang XR; Zhou JH; Yuan HZ; Yang Y; Huang TT; Liu DP; Liu YQ
    J Assist Reprod Genet; 2020 Dec; 37(12):3143-3150. PubMed ID: 33094428
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective clinical evaluation of Momguard non-invasive prenatal test in 1011 Korean high-risk pregnant women.
    Hu HJ; Lee MY; Cho DY; Oh M; Kwon YJ; Han YJ; Ryu HM; Kim YN; Won HS
    J Obstet Gynaecol; 2020 Nov; 40(8):1090-1095. PubMed ID: 31826681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical application of expanded noninvasive prenatal testing for fetal chromosome abnormalities in a cohort of 39,580 pregnancies.
    Chen Y; Lu L; Zhang Y; Wang F; Ni Y; Wang Q; Ying C
    Am J Med Genet A; 2022 May; 188(5):1426-1434. PubMed ID: 35107205
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical Application of Cell-Free DNA Sequencing-Based Noninvasive Prenatal Testing for Trisomies 21, 18, 13 and Sex Chromosome Aneuploidy in a Mixed-Risk Population in Iran.
    Garshasbi M; Wang Y; Hantoosh Zadeh S; Giti S; Piri S; Reza Hekmat M
    Fetal Diagn Ther; 2020; 47(3):220-227. PubMed ID: 31487708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The accuracy and feasibility of noninvasive prenatal testing in a consecutive series of 20,626 pregnancies with different clinical characteristics.
    Zheng Y; Li J; Zhang J; Yang H
    J Clin Lab Anal; 2022 Oct; 36(10):e24660. PubMed ID: 36099005
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Application of non-invasive prenatal testing to 91,280 spontaneous pregnancies and 3477 pregnancies conceived by in vitro fertilization.
    Wei R; Li J; Xia Y; Wang C; Lu X; Fang Y; Zhu J
    Mol Cytogenet; 2023 Sep; 16(1):25. PubMed ID: 37726793
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Retrospective analysis of cell-free fetal DNA prenatal testing of maternal peripheral blood].
    Wei Y; Wang R; Xi M; Wei L; Zhu W; Liu Y
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2023 Aug; 40(8):933-938. PubMed ID: 37532491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective analysis of 44 578 pregnancies undergoing non-invasive prenatal testing in Weifang].
    Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2020 Oct; 37(10):1065-1068. PubMed ID: 32924102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the performance of NIPT and NIPT-plus for fetal chromosomal aneuploidy and high Z-score increases the positive predictive value.
    Liu S; Xu Y; Chang Q; Jia B; Li F
    Int J Gynaecol Obstet; 2024 Oct; 167(1):273-280. PubMed ID: 38651210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Prenatal diagnosis and outcome of pregnancy for women with high risks by screening of fetal free DNA from peripheral blood samples].
    Li Z; Duan H; Liu W; Zhu R; Li J
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Jan; 41(1):1-7. PubMed ID: 38171551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analysis of cell-free fetal DNA in maternal blood for detection of trisomy 21, 18 and 13 in a general pregnant population and in a high risk population - a systematic review and meta-analysis.
    Iwarsson E; Jacobsson B; Dagerhamn J; Davidson T; Bernabé E; Heibert Arnlind M
    Acta Obstet Gynecol Scand; 2017 Jan; 96(1):7-18. PubMed ID: 27779757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.